Overall, our study suggests the advantages of chromium supplementation on lowering inflammatory markers through improving gene expression of PPAR-γ, GLUT-1, LDLR, and IL-1in infertile women with PCOS who were candidate for IVF. The gene discussed is LDLR; the disease is polycystic ovary syndrome.